TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06673797

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Effects of Swiss Ball exercises
Description: Effects of Swiss ball exercises along with stretching as baseline treatment.~1. Stretching of hamstrings, calf, and quads for 10 seconds hold 5 times.~2. Swiss ball exercises. a.Sitting on the Swiss ball with the trunk straight, arms by the sides, and eyes opened progressed towards eyes closed for 10 seconds, then rest. b.Sitting on the Swiss ball with trunk straight and arm by the sides. The therapist would assist the patient to engage the patient in shifting the body's weight to one side and the other side sideways as well as anterior and posterior and up and down alternatively. Start with 10 repetitions. c. Standing with gym ball in front. The therapist would stand behind the patient to provide support and ask the patient to lean forward on the gym ball with both hands via outstretched arms. Start with 10 repetitions d. One leg weight bearing on a gym ball with the therapist behind the patient, gripping the patient's pelvis to provide support. Start with 10 repetitions

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EFFECTS OF FRENKEL EXERCISES ON STATIC AND DYNAMIC BALANCE IN ATAXIC CHILDREN WITH CEREBRAL PALSY
Description: Frenkel Exercises along with stretching as baseline treatment. The second intervention group would participate in Frenkel Exercises along with stretching as baseline treatment. The exercises would be performed 3 times per week for four weeks.~1. Stretching of hamstrings, calf, and quads for 10 seconds hold 5 times. (11)~   a. Calf stretching. b. Hamstring stretches. c. Quads stretching~2. Frenkel\&#39;s lower limb exercises are the exercises listed below. The time of each session was set to be 10 minutes in the first week and then raised by 5 minutes every week. The patients were given 5 minutes to relax after 10 minutes of practice. (12)~   1. Supine lying~  2. While sitting~  3. Stride standing
Study: NCT06678984

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: with treated umbilical vein allograft
Description: Surgical treatment of female stress urinary incontinence using a treated allogeneic umbilical vein sling

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: with autologous fascial pubovaginal sling
Description: Surgical treatment of female stress urinary incontinence using a autologous fascial pubovaginal sling
Study: NCT06674668

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vibrotactile stimulation
Description: The intervention includes traditional physiotherapy and 20 minutes of vibrotactile device use. As traditional physiotherapy, 30 seconds of 8 repetitions of passive wrist stretching exercises, radial head mobilization and deep friction massage will be applied to the affected extremity. Afterwards, the Intellinetix Elbow Wearable Vibration Device providing vibration will be worn on the affected tissue. The patient will remain in a comfortable position on the treatment table with the affected extremity for 20 minutes (10 minutes × 2).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional physiotherapy
Description: For traditional physiotherapy, passive stretching exercises, radial head mobilization and deep friction massage will be applied to the affected extremity. Stretching exercises will be performed on the wrist flexor and extensor muscles for 30 seconds and 8 repetitions. Mill's manipulation, described by James Cyriax, will be applied once for radial head mobilization. The treatment will be completed with a 5-minute deep friction massage, affecting the wrist extensor muscle tendons and their ending points.
Study: NCT06088563

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Vaccine injection
Description: Injection of the vaccine in renal transplant patients.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Vaccine injection
Description: Injection of the vaccine in renal transplant patients.
Study: NCT06679062

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Suvorexant
Description: Suvorexant is described chemically as: \[(7R)-4-(5-chloro-2-benzoxazolyl) hexahydro-7-methyl-1H-1,4-diazepin-1-yl\]\[5-methyl-2-(2H-1,2,3-triazol2-yl)phenyl\]methanone. SUV's empirical formula is C23H23ClN6O2 and the molecular weight is 450.92. Each film coated tablet contains 10mg or 20mg of suvorexant.
Study: NCT06132828

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DR30206
Description: Subjects receive DR30206 intravenously
Study: NCT05262959

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donafenib, PD-1
Description: Eligible subjects will receive Donafenib combined with PD-1 and TACE. Donafenib will be taken orally twice a day, 0.1mg each time.PD-1 will be used intravenously every 3 weeks.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TACE
Description: TACE will be performed by the investigator based on the patient's tumor status.
Study: NCT04319783

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Darolutamide
Description: Darolutamide alone

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Darolutamide
Description: Darolutamide alone

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Darolutamide + Consolidation Radiotherapy
Study: NCT05950139

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Peptide vaccine
Description: Peptide vaccine
Study: NCT06053008

Intervention type: OTHER
Group type: OTHER
Intervention: The relationship between pain perception, temporomandibular joint disorder severity and spine health
Description: The relationship between pain perception, temporomandibular joint disorder severity and spine health
Study: NCT04428437

Intervention type: DRUG
Intervention: Lenvatinib
Description: Prescribed by physician.
Study: NCT06659718

Intervention type: DRUG
Intervention: Oral semaglutide
Description: New use of oral semaglutide dispensing claim is used as the exposure.

Intervention type: DRUG
Intervention: Sitagliptin
Description: New initiation of sitagliptin dispensing claim is used as the reference.
Study: NCT06379425

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: Will add additional medications celecoxib and gabapentin to acetaminophen preoperatively prior to patient surgery

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: Will add additional medications celecoxib and gabapentin to acetaminophen preoperatively prior to patient surgery

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celecoxib
Description: Will add additional medications celecoxib and gabapentin to acetaminophen preoperatively prior to patient surgery

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin
Description: Will add additional medications celecoxib and gabapentin to acetaminophen preoperatively prior to patient surgery
Study: NCT05368077

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Description: Adenotonsillectomy is a standard surgical procedure for pediatric OSA treatment, which involves removal of hypertrophied tonsils and adenoids.
Study: NCT06233760

Intervention type: OTHER
Intervention: Rheumatic diseases Mistreatment Scale (RDMS)
Description: In 2012 Giraldo-Rodríguez developed and validated the Geriatric Mistreatment Scale (GAS), prior to its application, translation, cultural adaptation, and validation were performed.

Intervention type: OTHER
Intervention: Health Assessment Questionnaire (HAQ)
Description: The HAQ is based on five patient-centered dimensions: disability, pain, medication effects, costs of care, and mortality
Study: NCT06305598

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies
Study: NCT06679062

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Film coated tablet to match the active drug.
Study: NCT06305598

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone Cypionate
Description: Given IM
Study: NCT06404931

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vaginal hysterectomy plus matrix reinforcement and sacrospinous fixation with Anchorsure® device
Description: Vaginal hysterectomy plus matrix reinforcement and sacrospinous fixation with Anchorsure® device

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Vaginal hysterectomy plus anterior colporrhaphy
Description: Vaginal hysterectomy plus anterior colporrhaphy

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Vaginal hysterectomy plus sacrospinous fixation with Anchorsure® device
Description: Vaginal hysterectomy plus sacrospinous fixation with Anchorsure® device
Study: NCT06691503

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: mediastinoscopic-assisted transhiatal laparoscopic esophagectomy (MATLE)
Description: mediastinoscopic-assisted transhiatal laparoscopic esophagectomy (MATLE)
Study: NCT04347161

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Conversational Agent/Chatbot
Description: Via text messages, the bidirectional, conversation agent provides specific dosing instructions and motivational reminders to promote oral targeted therapy adherence and symptom management. Patients can report symptoms at any time via text message and are also prompted to report symptoms and medication adherence at periodic intervals. Reported symptoms are monitored and managed algorithmically according severity. High-grade symptoms are triaged directly to the patients' cancer care team. Patients in the intervention arm will use MEMS caps to enable capture of the primary outcome and asked to complete longitudinal surveys.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Patients in the control arm will receive usual care, which includes receiving information about dosing and self-administration of oral therapy, and anticipatory guidance for patients regarding management of side effects. Patients in the control arm will use MEMS caps to enable capture of the primary outcome and asked to complete longitudinal surveys.
Study: NCT05935748

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NKT2152
Description: Oral HIF2a inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NKT2152
Description: Oral HIF2a inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NKT2152
Description: Oral HIF2a inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NKT2152
Description: Oral HIF2a inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: palbociclib
Description: a cyclin-dependent kinases (CDK) 4 and 6 inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: palbociclib
Description: a cyclin-dependent kinases (CDK) 4 and 6 inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: palbociclib
Description: a cyclin-dependent kinases (CDK) 4 and 6 inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: palbociclib
Description: a cyclin-dependent kinases (CDK) 4 and 6 inhibitor

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sasanlimab
Description: an immunoglobulin G4 (IgG4) monoclonal antibody that blocks PD-1; a solution for injection for subcutaneous administration
Study: NCT06687824

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Black Tea
Description: Sterile gauze is impregnated into specific volume of black tea-extract

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Colour-blinded Sterile Gauze
Description: Diluted povidone-iodine is added into sterile gauze to colour blind the involved subject and the operator
Study: NCT06689319

Intervention type: BEHAVIORAL
Intervention: Assessment of Artificial Intelligence Literacy
Description: The Artificial Intelligence Literacy Scale will be used to determine the level of AI literacy.. The scale is a 12-item instrument designed to measure individuals' knowledge and skills in AI awareness, usage, evaluation, and ethical considerations. Items are rated on a Likert scale from 1 to 7 (1: Strongly Disagree, 7: Strongly Agree), with some items reverse-coded (items 2, 5, and 11). The minimum possible score on the scale is 12, and the maximum score is 84; a higher score indicates a higher level of AI literacy. The Turkish version of the scale will be used in this study.
Study: NCT06688487

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: early extubation of hypoxemic patients
Description: patient extubated after the spontaneous ventilation trial despite the presence of hypoxemia defined by SpO2 ≤ 90% either in T-piece under 6 L/min, or under FiO2 = 40% if SBT is performed in spontaneous ventilation with minimal inspiratory assistance.
Study: NCT05935748

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sasanlimab
Description: an immunoglobulin G4 (IgG4) monoclonal antibody that blocks PD-1; a solution for injection for subcutaneous administration
Study: NCT05649748

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treprostinil Palmitil
Description: Administered by oral inhalation, using a Plastiape capsule-based dry powder inhaler.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Administered by oral inhalation using a Plastiape capsule-based dry powder inhaler
Study: NCT06297265

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lymphedema Management
Description: Undergo MLD breast massage
Study: NCT02005523

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RNS60

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Study: NCT06297265

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Adjuvant breast radiation therapy
Description: Using standard 3D conformal or intensity modulated techniques, patients will receive standard fractionation or moderate hypofractionation radiation therapy. The radiation treatment will last for 3 to 6 weeks, with the length of treatment depending on patient's specific clinical situation.
Study: NCT06512311

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CBMed Drug Screening Plattform
Description: The main devices used within the drug screening process are purchased from PerkinElmer, Liconic Instruments, BioTek and Beckman Coulter Diagnostics.
Study: NCT05079880

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 300 mg of caffeine citrate infusion
Description: At the end of the surgery, the study drug was given intravenously over ten minutes than the sevoflurane infusion was stopped corresponding to the start of the recovery period

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: At the end of the surgery, the placebo was given intravenously over ten minutes than the sevoflurane infusion was stopped corresponding to the start of the recovery period
Study: NCT06279754

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Human Endostatin Injection
Description: Recombinant Human Endostatin Injection：210 mg, intravenous infusion for 72 hours, once every three weeks cycle Evafolimab Injection：Subcutaneous injection on day 1, 8, and 15, once every three weeks cycle
Study: NCT06292624

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent vacuum therapy (Weyergans High Care® Medial, Germany)
Description: The participants' lower limb will be placed in the vacuum chamber and sealed with a cuff. The maximum negative pressure applied in the experimental group would be -40mmHg (negative pressure/ambient pressure phase: 9s / 7s). The parameters are selected based on the manufacturer's recommendations.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cycling exercise
Description: The participant will perform 20 minutes of cycling exercise. Aiming at reaching a moderate exercise intensity (50% - 70%) of maximal heart rate on a gym bike.
Study: NCT05513001

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LOU064 (blinded)
Description: LOU064 (blinded) active treatment

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LOU064 (open label)
Description: LOU064 (open-label) active treatment

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: LOU064 (open label)
Description: LOU064 (open-label) active treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LOU064 (open label)
Description: LOU064 (open-label) active treatment
Study: NCT04298606

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
Description: Given IM
Study: NCT06688409

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: awake ABPM
Description: Comparison of a BP measured with the home BP devices and the average awake ABPM performed immediately after

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: awake ABPM
Description: Comparison of a BP measured with the home BP devices and the average awake ABPM performed immediately after
Study: NCT00917228

Intervention type: DEVICE
Intervention: recordings with device equipped

Intervention type: DEVICE
Intervention: Control
Description: Recording without device equipped
Study: NCT06392516

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketoacid
Description: 250 ml ketoacid two hours before the hemodialysis session ended
Study: NCT06688409

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: awake ABPM
Description: Comparison of a BP measured with the home BP devices and the average awake ABPM performed immediately after
Study: NCT04783324

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: E-Mobile Health Application
Description: The e-mobile health application prepared by the researcher will be used. E-mobile health application include information about postpartum care.
Study: NCT05050487

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PENG block
Description: The PENG block is performed under US guid¬ance, . The pa¬tient is placed in the supine position a curvilinear low-fre¬quency ultrasound probe (2-5 MHz) is initially placed in a transverse plane over the AIIS and then aligned with the pubic ramus by rotating the probe approximately 30-45 degrees . .~The needle, usually a 22-G80-mm echogenic device, is inserted from lateral to medial with an in-plane approach to place the tip in the plane between the psoas tendon anteriorly and the pu¬bic ramus posteriorly .~After needle insertion and following negative aspiration, the local anesthetic is injected . The volume used of 20 ml of(L-bupivacaine; concentration 0,25% ) . This fascial plane appeared to continue in the hip pericapsular plane.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lumbar erector spinae plane block
Description: The lumbar erector spinae block is performed under US guid¬ance, after adequate skin disinfection The patient is placed in the lateral decubitus position according to the selected site of surgical intervention.~The 4th lumbar vertebral level will determined The convex USG transducer was placed at the mid-vertebral line in the sagittal plane. The transducer was shifted from the midline, 3.5-4 cm laterally to the side of the surgery to visualize the erector spinae muscle and transverse process . 0.5-1 ml of the prepared LA solution (20 ml bupivacaine 0.25%). All LA was administered to this location between the transverse process and the erector spinae muscle.
Study: NCT04689646

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mind Body Intervention 1
Description: Mind body techniques for Intervention 1 will be taught in lectures and group discussion sessions.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mind body intervention 2
Description: Mind body techniques for Intervention 2 will be taught in lectures and group and/or individual sessions.
Study: NCT03915691

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Catheter ablation of atrial tachycardia: Ripple Mapping guided.
Description: Ripple Mapping is used to map the atrial tachycardia mechanism. Using the scar thresholding technique the Ripple Map is interpreted and catheter ablation directed to the site of the heart identified as putative to the arrhythmia mechanism. All ablation lesions are confirmed to have conduction block across them using Ripple Mapping. This can include lesions created at previous ablation procedures.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Catheter ablation of atrial tachycardia: Conventional mapping guided.
Description: Conventional activation mapping is used to map the atrial tachycardia mechanism. The resultant (activation) map is interpreted and ablation directed to the site of the heart identified as putative to the arrhythmia mechanism. All ablation lesions are confirmed to have conduction block across them using conventional mapping. This can include lesions created at previous ablation procedures.
Study: NCT06316089

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PrEPared for Release
Description: A multilevel, behavioral and navigation intervention administered over two sessions to promote PrEP initiation, adherence and linkage to PrEP care in the community for incarcerated men with a history of injection drug use.
Study: NCT05679726

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: massage
Description: reflexology foot massage
Study: NCT06233760

Intervention type: OTHER
Intervention: Depression, Anxiety and Stress Scale (DASS-21)
Description: DASS-21 is a set of three self-report scales designed to measure the emotional states of depression, anxiety, and stress. Each of the three DASS-21 scales contains 7 items, divided into subscales with similar content

Intervention type: OTHER
Intervention: Brief Resilient Coping Scale
Description: Brief Resilient Coping Scale is a 4-item measure designed to capture tendencies to cope with stress in a highly adaptive manner
Study: NCT06133777

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Respiratory variability monitoring
Description: Respiratory variability will be measured using a belt equipped with an external sensor allowing automatic and continuous analysis of thoracic movement by frequency analysis
Study: NCT06141460

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RRG001
Description: Administered via Subretinal injection. Dosage form: injection solution.
Study: NCT04778384

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Micro-training to promote self-management in pain therapy
Description: Micro-training according to the checklist \& targeted discussion / dismantling of patient-related barriers based on the answers in the second part of the questionnaire (BQII Barriers Questionnaire) In this discussion, the nurses give their opinion on any patient-related barriers that become apparent after completing the second part of the questionnaire. This is not done according to a fixed template, but with the specialist knowledge and everyday experience of the nurse.